INTRODUCTION: Hemorrhagic shock is a major cause of death after trauma. An additional blunt chest trauma independently contributes to mortality upon the development of an acute lung injury (ALI) by aggravating pathophysiological consequences of hemorrhagic shock. The maintenance of hydrogen sulfide availability is known to play an important role during hemorrhage and ALI. We therefore tested the impact of a genetic 3-mercaptopyruvate sulfurtransferase mutation (Δ3-MST) in a resuscitated murine model of traumatic-hemorrhagic shock. METHODS: Anesthetized wild-type (WT) and Δ3-MST mice underwent hemorrhagic shock with/without blunt chest trauma. Hemorrhagic shock was implemented for 1 h followed by retransfusion of shed blood and intensive care therapy for 4 h, including lung-protective mechanical ventilation, fluid resuscitation, and noradrenaline titrated to maintain a mean arterial pressure at least 50 mmHg. Systemic hemodynamics, metabolism, and acid-base status were assessed together with lung mechanics and gas exchange. Postmortem tissue samples were analyzed for immunohistological protein expression and mitochondrial oxygen consumption. RESULTS: 3-MST-deficient mice showed similar results in parameters of hemodynamics, gas exchange, metabolism, acid base status, and survival compared with the respective WT controls. Renal albumin extravasation was increased in Δ3-MST mice during hemorrhagic shock, together with a decrease of LEAK respiration in heart tissue. In contrast, mitochondrial oxygen consumption in the uncoupled state was increased in kidney and liver tissue of Δ3-MST mice subjected to the combined trauma. CONCLUSIONS: In summary, in a resuscitated murine model of traumatic-hemorrhagic shock, 3-MST deficiency had no physiologically relevant impact on hemodynamics and metabolism, which ultimately lead to unchanged mortality regardless of an additional blunt chest trauma.
INTRODUCTION:Hemorrhagic shock is a major cause of death after trauma. An additional blunt chest trauma independently contributes to mortality upon the development of an acute lung injury (ALI) by aggravating pathophysiological consequences of hemorrhagic shock. The maintenance of hydrogen sulfide availability is known to play an important role during hemorrhage and ALI. We therefore tested the impact of a genetic 3-mercaptopyruvate sulfurtransferase mutation (Δ3-MST) in a resuscitated murine model of traumatic-hemorrhagic shock. METHODS: Anesthetized wild-type (WT) and Δ3-MSTmice underwent hemorrhagic shock with/without blunt chest trauma. Hemorrhagic shock was implemented for 1 h followed by retransfusion of shed blood and intensive care therapy for 4 h, including lung-protective mechanical ventilation, fluid resuscitation, and noradrenaline titrated to maintain a mean arterial pressure at least 50 mmHg. Systemic hemodynamics, metabolism, and acid-base status were assessed together with lung mechanics and gas exchange. Postmortem tissue samples were analyzed for immunohistological protein expression and mitochondrial oxygen consumption. RESULTS: 3-MST-deficient mice showed similar results in parameters of hemodynamics, gas exchange, metabolism, acid base status, and survival compared with the respective WT controls. Renal albumin extravasation was increased in Δ3-MSTmice during hemorrhagic shock, together with a decrease of LEAK respiration in heart tissue. In contrast, mitochondrial oxygen consumption in the uncoupled state was increased in kidney and liver tissue of Δ3-MSTmice subjected to the combined trauma. CONCLUSIONS: In summary, in a resuscitated murine model of traumatic-hemorrhagic shock, 3-MST deficiency had no physiologically relevant impact on hemodynamics and metabolism, which ultimately lead to unchanged mortality regardless of an additional blunt chest trauma.
Authors: Florian Wagner; Angelika Scheuerle; Sandra Weber; Bettina Stahl; Oscar McCook; Markus W Knöferl; Markus Huber-Lang; Daniel H Seitz; Jörg Thomas; Pierre Asfar; Csaba Szabó; Peter Möller; Florian Gebhard; Michael Georgieff; Enrico Calzia; Peter Radermacher; Katja Wagner Journal: J Trauma Date: 2011-12
Authors: Chirag V Shah; A R Localio; Paul N Lanken; Jeremy M Kahn; Scarlett Bellamy; Robert Gallop; Barbara Finkel; Vicente H Gracias; Barry D Fuchs; Jason D Christie Journal: Crit Care Med Date: 2008-08 Impact factor: 7.598
Authors: Hamid Aslami; Wilco P Pulskens; Maria T Kuipers; Aafkeline P Bos; André B P van Kuilenburg; Ronald J A Wanders; Jeroen Roelofsen; Joris J T H Roelofs; Raphaela P Kerindongo; Charlotte J P Beurskens; Marcus J Schultz; Wim Kulik; Nina C Weber; Nicole P Juffermans Journal: PLoS One Date: 2013-05-23 Impact factor: 3.240
Authors: Katja Wagner; Michael Gröger; Oscar McCook; Angelika Scheuerle; Pierre Asfar; Bettina Stahl; Markus Huber-Lang; Anita Ignatius; Birgit Jung; Matthias Duechs; Peter Möller; Michael Georgieff; Enrico Calzia; Peter Radermacher; Florian Wagner Journal: PLoS One Date: 2015-07-30 Impact factor: 3.240
Authors: Martin Wepler; Jonathan M Preuss; Tamara Merz; Clair Hartmann; Ulrich Wachter; Oscar McCook; Josef Vogt; Sandra Kress; Michael Gröger; Marina Fink; Angelika Scheuerle; Peter Möller; Enrico Calzia; Ute Burret; Peter Radermacher; Jan P Tuckermann; Sabine Vettorazzi Journal: Front Immunol Date: 2020-01-23 Impact factor: 7.561
Authors: Tamara Merz; Nicole Denoix; Martin Wepler; Holger Gäßler; David A C Messerer; Clair Hartmann; Thomas Datzmann; Peter Radermacher; Oscar McCook Journal: Intensive Care Med Exp Date: 2020-12-18
Authors: Martin Wepler; Jonathan M Preuss; Cornelia Tilp; Martina Keck; Jochen Blender; Ulrich Wachter; Tamara Merz; Josef Vogt; Sandra Kress; Michael Gröger; Andrea Hoffmann; Marina Fink; Enrico Calzia; Ute Burret; Peter Radermacher; Jan P Tuckermann; Sabine Vettorazzi Journal: Front Immunol Date: 2022-09-12 Impact factor: 8.786